Germany ∙ The Albiglutide Controversy: A Paradigm Shift in Pricing Negotiations? journal article Christian Stallberg European Pharmaceutical Law Review, Volume 1 (2017), Issue 1, Page 37 - 41
Are You AI’S Favourite? EU Legal Implications of Biased AI Systems in Clinical Genetics and Genomics Anastasiya Kiseleva, Paul Quinn
A Case of Unforeseen Adverse Side-Effects? The Ireland/Northern Ireland Protocol and Medicines Regulation George Peretz, Xisca Borrás